NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

7669Listed tickers in the SEC universe 1972Issuers with current reporting periods 451Issuers with both EPS and ROE metrics 2026-09-21Fundamentals evaluated as of

Example screens

Example lists from a senior trader

Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

1972 companies match

Showing 1251–1275 of 1972 · page 51/79

Per page 2550100
CompanyCombined rankEPS accelerationRevenue growthROENet margin Reporting period
CMRCCommerce.com, Inc.NASDAQ 0.1% -11.2% -1.7% 2026-06-30Filed 2026-08-06
CMTGClaros Mortgage Trust, Inc.NYSE -42.5% 2026-06-30Filed 2026-07-29
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/NASDAQ -16.4% -47.7% -5.5% 2026-04-30Filed 2026-06-15
CNCCENTENE CORPNYSE 4.5% -22.6% -2.9% 2026-06-30Filed 2026-07-28
CNDTCONDUENT IncNASDAQ -11.9% 2026-06-30Filed 2026-08-10
CNETZW Data Action Technologies Inc.NASDAQ 19.0% -20.1% -23.9% 2026-06-30Filed 2026-08-14
CNKCinemark Holdings, Inc.NYSE 18.9% 5.3% 2026-03-31Filed 2026-05-01
CNMDCONMED CorpNYSE 0.3% 2026-06-30Filed 2026-07-29
CNNECannae Holdings, Inc.NYSE -7.3% -17.5% -41.1% 2026-06-30Filed 2026-08-10
CNOBConnectOne Bancorp, Inc.NASDAQ 9.8% 2026-06-30Filed 2026-08-04
CNPCENTERPOINT ENERGY INCNYSE 0.6% 9.4% 11.4% 2026-03-31Filed 2026-04-23
CNRCore Natural Resources, Inc.NYSE 3.5% 2.7% 2.3% 2026-06-30Filed 2026-08-06
CNSPCNS Pharmaceuticals, Inc.NASDAQ -91.8% 2026-06-30Filed 2026-08-12
CNSYCERENOME, INC.NASDAQ -70.4% -477.5% -620.7% 2026-06-30Filed 2026-08-14
CNTBConnect Biopharma Holdings LtdNASDAQ 5666.7% -256.8% -2336.3% 2026-06-30Filed 2026-08-12
CNTNCanton Strategic Holdings, Inc.NASDAQ -21.6% 2026-06-30Filed 2026-08-14
CNTXContext Therapeutics Inc.NASDAQ -120.4% 2026-06-30Filed 2026-08-05
CNTYCENTURY CASINOS INC /CO/NASDAQ 0.8% -9.6% 2026-06-30Filed 2026-08-07
CNVSCineverse Corp.NASDAQ 175.2% 2026-06-30Filed 2026-08-13
CNXCNX Resources CorpNYSE -35.7% 19.6% 36.5% 2026-06-30Filed 2026-07-30
CNXUConexeu Sciences Inc.NASDAQ 2026-04-30Filed 2026-06-15
COAGHemab Therapeutics Holdings, Inc.NASDAQ 2026-06-30Filed 2026-08-11
COCHEnvoy Medical, Inc.NASDAQ -34.6% -708.5% -11304.8% 2026-06-30Filed 2026-08-10
COCPCocrystal Pharma, Inc.NASDAQ -951.9% 2026-06-30Filed 2026-08-13
CODICompass Diversified HoldingsNYSE -11.4% -20.1% -5.3% 2026-06-30Filed 2026-08-10

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-09-18. Source: FRED / Federal Reserve.